miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1

Background: Nowadays, microRNAs (miRNAs) attract much attention in regulating anticancer drug resistance in cancers including multiple myeloma (MM). Bortezomib is the first-line choice in MM treatment, and bortezomib resistance caused by aberrant DNA repair leads to the recurrence and therapeutic fa...

Full description

Saved in:
Bibliographic Details
Published in:Cell Cycle
Main Authors: Yuan, Xiaoli, Ma, Rongjun, Yang, Shiwei, Jiang, Li, Wang, Zhen, Zhu, Zunmin, Li, Hongwei
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2019
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6619958/
https://ncbi.nlm.nih.gov/pubmed/31204563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2019.1632138
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items